Dachaigh › Leukemia myelomonocytic inbheach
Sgrùdaidhean clionaigeach Leukemia myelomonocytic inbheach a’ fastadh anns na SA
Tha 9 sgrùdaidhean airson Leukemia myelomonocytic inbheach a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Philadelphia, PA4 sgrùdaidhean
- Minneapolis, MN4 sgrùdaidhean
- Boston, MA3 sgrùdaidhean
- Seattle, WA3 sgrùdaidhean
- New York City, NY3 sgrùdaidhean
- Washington, DC3 sgrùdaidhean
- Cincinnati, OH3 sgrùdaidhean
- Atlanta, GA3 sgrùdaidhean
- Indianapolis, IN3 sgrùdaidhean
- Memphis, TN3 sgrùdaidhean
- Ann Arbor, MI3 sgrùdaidhean
- Chicago, IL3 sgrùdaidhean
- San Francisco, CA3 sgrùdaidhean
Le stàit
- California3 sgrùdaidhean
- Colorado3 sgrùdaidhean
- Florida3 sgrùdaidhean
- Georgia3 sgrùdaidhean
- Illinois3 sgrùdaidhean
- Indiana3 sgrùdaidhean
- Massachusetts3 sgrùdaidhean
- Michigan3 sgrùdaidhean
- Minnesota4 sgrùdaidhean
- Missouri3 sgrùdaidhean
- New York3 sgrùdaidhean
- Ohio3 sgrùdaidhean
- Pennsylvania4 sgrùdaidhean
- Sgìre Cholumbia3 sgrùdaidhean
- Tennessee3 sgrùdaidhean
- Texas3 sgrùdaidhean
- Washington3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
A’ fastadhÌre 1/2
1 Month – 21 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
A’ fastadhÌre 1
Aoisean 1 gu 18 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A’ fastadhÌre 1/2
Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
A’ fastadh
Suas gu aois 25 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT03810196Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
A’ fastadhÌre 2
Suas gu aois 60 · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT03314974A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
A’ fastadhÌre 1
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT04024761Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
A’ fastadhÌre 2
6 Months – 39 Years · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT05800210HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
A’ fastadhÌre 1
Suas gu aois 80 · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT03326921MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
A’ fastadhÌre 2
Suas gu aois 60 · Gach gnè · Air ùrachadh 6 Gibl 2026 · NCT05735717Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.